blog
Congressional offices consider making xylazine a controlled substance
With illicit xylazine increasingly showing up in street drugs that pose grave risks to human users, government policymakers are discussing making it a…
AVMA news
USDA awards $56M to support research on SARS-CoV-2 in animals
Findings from the 36 research projects related to SARS-CoV-2 in animal populations that the U.S. Department of Agriculture’s Animal and Plant Health…
AVMA news
Global Health Summit to focus on infectious diseases, biodiversity
Infectious diseases and the importance of biodiversity is the theme for the 2023 Global Health Summit (GHS), slated for Monday, July 17, during AVMA…
AVMA news
USDA developing new tools to identify SARS-CoV-2 in wild, domestic animals
U.S. Department of Agriculture scientists are developing new tests and tools to identify and track the SARS-CoV-2 virus and its variants in wild and…
AVMA news
AVMA president among veterinarians joining National Academies of Practice
AVMA President Lori Teller, Dr. Julia Ponder, and Dr. John Tegzes were recently inducted as 2023 veterinary fellows into the National Academies of…
AVMA news
Canine osteoarthritis drug, Lyme disease bacteria vaccine receive approvals
Two recent drug approvals mean a novel treatment for the control of canine osteoarthritis (OA) pain and an oral vaccine against the wildlife spread of…